141 related articles for article (PubMed ID: 3809073)
1. Antibodies to the thyroid gland and to the thyrotrophin receptor in African and Indian thyrotoxic patients.
Desai RK; Jialal I; Omar MA; Rajput MC; Joubert SM
Postgrad Med J; 1986 Sep; 62(731):837-9. PubMed ID: 3809073
[TBL] [Abstract][Full Text] [Related]
2. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
[TBL] [Abstract][Full Text] [Related]
3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
4. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
Paschke R; Vogg M; Swillens S; Usadel KH
J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
6. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
7. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
[TBL] [Abstract][Full Text] [Related]
8. Thyroid autoimmunity and thyroid autonomy.
Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A
Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187
[TBL] [Abstract][Full Text] [Related]
9. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
10. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
11. Protein-A purified human immunoglobulins: a comparison of thyroid stimulating and thyrotrophin receptor binding activities in thyrotoxicosis.
Reader SC; Davison B; Beardwell C; Ratcliffe JG; Robertson WR
Clin Endocrinol (Oxf); 1986 Oct; 25(4):441-51. PubMed ID: 2887306
[TBL] [Abstract][Full Text] [Related]
12. Human thyrotropin receptor subunits characterized by thyrotropin affinity purification and western blotting.
Leedman PJ; Newman JD; Harrison LC
J Clin Endocrinol Metab; 1989 Jul; 69(1):134-41. PubMed ID: 2471709
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy.
Zouvanis M; Panz VR; Kalk WJ; Joffe BI
J Endocrinol Invest; 1998 Dec; 21(11):771-4. PubMed ID: 9972678
[TBL] [Abstract][Full Text] [Related]
14. [The significance of microsomal antibodies, thyroglobulin antibodies, thyrotropin receptor antibodies in the diagnosis of thyroid diseases].
Horster FA
Internist (Berl); 1988 Aug; 29(8):538-40. PubMed ID: 3053504
[No Abstract] [Full Text] [Related]
15. The implications of "thyroid-growth-immunoglobulins" (TGI) for the understanding of sporadic nontoxic nodular goitre.
Doniach D; Chiovato L; Hanafusa T; Bottazzo GF
Springer Semin Immunopathol; 1982; 5(4):433-46. PubMed ID: 6131546
[No Abstract] [Full Text] [Related]
16. Serum immunoglobulin G4 levels and Graves' disease phenotype.
Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
[TBL] [Abstract][Full Text] [Related]
17. Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.
Smyth PP; McMullan NM; Grubeck-Loebenstein B; O'Donovan DK
Acta Endocrinol (Copenh); 1986 Mar; 111(3):321-30. PubMed ID: 2870597
[TBL] [Abstract][Full Text] [Related]
18. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
[TBL] [Abstract][Full Text] [Related]
19. Immunological characterization of mononuclear cells in thyroid gland and blood in Graves' disease, multinodular goiter and papillary carcinoma.
Aanderud S; Matre R; Varhaug JE
Int Arch Allergy Appl Immunol; 1982; 69(2):137-42. PubMed ID: 6896702
[TBL] [Abstract][Full Text] [Related]
20. Altered immunoreactivity of thyroglobulin in thyroid disease.
Kim PS; Dunn AD; Dunn JT
J Clin Endocrinol Metab; 1988 Jul; 67(1):161-8. PubMed ID: 3379131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
